Clinical Trial Update: The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating the effects of glycine on atherosclerosis and metabolic syndrome–related parameters. The current status of the study is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Diabetes Mellitus
• Dyslipidemia
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Glycine (glycine)

Snippet

Sponsor: Prof. Tony hayek MD | Conditions: Metabolic Syndrome, Dyslipidemias | Phase 2, Phase 3 | Status: UNKNOWN